Retinal degeneration in mice lacking the γ subunit of the rod cGMP phosphodiesterase

Science

Volumn 272, Issue 5264, 1996, Pages 1026-1029

  Tsang, Stephen H ^a   Gouras, Peter ^b   Yamashita, Clyde K ^c   Kjeldbye, Hild ^b   Fisher, John ^a,d   Farber, Debora B ^c   Goff, Stephen P ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b New York Presbyterian Hospital   (United States)

^c JULES STEIN EYE INSTITUTE   (United States)

^d REGENERON PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP PHOSPHODIESTERASE;

ANIMAL MODEL; ARTICLE; ENZYME LOCALIZATION; ENZYME SUBUNIT; GENE MUTATION; GENE TARGETING; MOUSE; NONHUMAN; PHOTOTRANSDUCTION; PRIORITY JOURNAL; RETINA DEGENERATION; RETINITIS PIGMENTOSA;

EID: 0029740113     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.272.5264.1026     Document Type: Article

References (50)

1. P. Humphries, P. Kenna, G. J. Farrar, Science 256, 804 (1992).
2. T. P. Dryja et al., Nature 343, 364 (1990); C. H. Sung et al., Proc. Natl. Acad. Sci. U.S.A. 88, 6481 (1991); V. C. Sheffield, G. A. Fishman, J. S. Beck, A. E Kimura, E. M. Stone, Am. J. Hum. Genet. 49, 699 (1991).
3. T. P. Dryja et al., Nature 343, 364 (1990); C. H. Sung et al., Proc. Natl. Acad. Sci. U.S.A. 88, 6481 (1991); V. C. Sheffield, G. A. Fishman, J. S. Beck, A. E Kimura, E. M. Stone, Am. J. Hum. Genet. 49, 699 (1991).
4. T. P. Dryja et al., Nature 343, 364 (1990); C. H. Sung et al., Proc. Natl. Acad. Sci. U.S.A. 88, 6481 (1991); V. C. Sheffield, G. A. Fishman, J. S. Beck, A. E Kimura, E. M. Stone, Am. J. Hum. Genet. 49, 699 (1991).
5. G. Connell et al., Proc. Natl. Acad. Sci. U.S.A. 88. 723 (1991); G, J, Farrar et al., Nature 354, 478 (1991); K, Kajiwara et al.,ibid., p, 480; G. H. Travis, J. G. Sutcliffe, D. Bok, Neuron 6, 61 (1991).
6. G. Connell et al., Proc. Natl. Acad. Sci. U.S.A. 88. 723 (1991); G, J, Farrar et al., Nature 354, 478 (1991); K, Kajiwara et al.,ibid., p, 480; G. H. Travis, J. G. Sutcliffe, D. Bok, Neuron 6, 61 (1991).
7. G. Connell et al., Proc. Natl. Acad. Sci. U.S.A. 88. 723 (1991); G, J, Farrar et al., Nature 354, 478 (1991); K, Kajiwara et al.,ibid., p, 480; G. H. Travis, J. G. Sutcliffe, D. Bok, Neuron 6, 61 (1991).
8. G. Connell et al., Proc. Natl. Acad. Sci. U.S.A. 88. 723 (1991); G, J, Farrar et al., Nature 354, 478 (1991); K, Kajiwara et al.,ibid., p, 480; G. H. Travis, J. G. Sutcliffe, D. Bok, Neuron 6, 61 (1991).
9. T. P. Dryja et al., Proc. Natl. Acad. Sci. U.S.A. 92, 10177 (1995); R. R. Mclnnes and R. A. Bascom, Nature Genet. 1, 155 (1992),
10. T. P. Dryja et al., Proc. Natl. Acad. Sci. U.S.A. 92, 10177 (1995); R. R. Mclnnes and R. A. Bascom, Nature Genet. 1, 155 (1992),
11. H. Kuhn and P. A. Hargrave, Biochemistry 20, 2410 (1981).
12. L. Stryer, J. Biol. Chem. 266, 10711 (1991); S, Yarfitz and J. B. Hurley, ibid. 269, 14329 (1994),
13. L. Stryer, J. Biol. Chem. 266, 10711 (1991); S, Yarfitz and J. B. Hurley, ibid. 269, 14329 (1994),
14. B. K.-K. Fung, J. B. Hurley, L, Stryer, Proc. Natl. Acad. Sci. U.S.A. 78, 152 (1981).
15. A. Sitaramayya, J. Harkness, J. H. Parkes, C. Gonzalez-Oliva. P. A. Liebman, Biochemistry 25, 651 (1986); T. G. Wensel and L. Stryer, Proteins Struct. Funct. Genet. 1, 90 (1986).
16. A. Sitaramayya, J. Harkness, J. H. Parkes, C. Gonzalez-Oliva. P. A. Liebman, Biochemistry 25, 651 (1986); T. G. Wensel and L. Stryer, Proteins Struct. Funct. Genet. 1, 90 (1986).
17. W. Baehr, M. J. Devlin, M. L. Applebury, J. Biol. Chem. 254, 11669 (1979); B. K.-K. Fung, J. H. Young, H. K. Yamane, I. Griswold-Prenner, Biochemistry 29, 2657 (1990); P. Deterre, J. Bigay, F. Forquet, M. Robert, M. Charbre, Proc. Natl. Acad. Sci. U.S.A. 85, 2424 (1988).
18. W. Baehr, M. J. Devlin, M. L. Applebury, J. Biol. Chem. 254, 11669 (1979); B. K.-K. Fung, J. H. Young, H. K. Yamane, I. Griswold-Prenner, Biochemistry 29, 2657 (1990); P. Deterre, J. Bigay, F. Forquet, M. Robert, M. Charbre, Proc. Natl. Acad. Sci. U.S.A. 85, 2424 (1988).
19. W. Baehr, M. J. Devlin, M. L. Applebury, J. Biol. Chem. 254, 11669 (1979); B. K.-K. Fung, J. H. Young, H. K. Yamane, I. Griswold-Prenner, Biochemistry 29, 2657 (1990); P. Deterre, J. Bigay, F. Forquet, M. Robert, M. Charbre, Proc. Natl. Acad. Sci. U.S.A. 85, 2424 (1988).
20. V. Y. Arshavsky and D. M. Bownds, Nature 357, 416 (1992).
21. N. Miki, J. M. Baraban, J. J. Keins, J. J. Boyce, M. W. Bitensky, J. Biol. Chem. 260, 6320 (1975).
22. K.-W. Yau, Invest. Ophthalmol. Vis. Sci. 35, 9 (1994).
23. C. Bowes et al., Nature 347, 677 (1990); S, J. Pittler and W. Baehr, Proc. Natl. Acad Sci. U.S.A. 88, 8322 (1991); C. Bowes et al., ibid. 90, 2955 (1993).
24. C. Bowes et al., Nature 347, 677 (1990); S, J. Pittler and W. Baehr, Proc. Natl. Acad Sci. U.S.A. 88, 8322 (1991); C. Bowes et al., ibid. 90, 2955 (1993).
25. C. Bowes et al., Nature 347, 677 (1990); S, J. Pittler and W. Baehr, Proc. Natl. Acad Sci. U.S.A. 88, 8322 (1991); C. Bowes et al., ibid. 90, 2955 (1993).
26. D. B. Farber, J. Danciger, G. Aguirre, Neuron 9, 349 (1992); M. L. Suber et al., Proc. Natl. Acad. Sci. U.S.A. 90, 3968 (1993); K. Ray, V. J. Baldwin, G. M. Acland, S. H. Blanton, G. D. Aguirre,Invest. Ophthalmol Vis. Sci. 35, 4291 (1994).
27. D. B. Farber, J. Danciger, G. Aguirre, Neuron 9, 349 (1992); M. L. Suber et al., Proc. Natl. Acad. Sci. U.S.A. 90, 3968 (1993); K. Ray, V. J. Baldwin, G. M. Acland, S. H. Blanton, G. D. Aguirre,Invest. Ophthalmol Vis. Sci. 35, 4291 (1994).
28. D. B. Farber, J. Danciger, G. Aguirre, Neuron 9, 349 (1992); M. L. Suber et al., Proc. Natl. Acad. Sci. U.S.A. 90, 3968 (1993); K. Ray, V. J. Baldwin, G. M. Acland, S. H. Blanton, G. D. Aguirre,Invest. Ophthalmol Vis. Sci. 35, 4291 (1994).
29. M. E. McLaughlin, T. L. Ehrhart, E. L. Berson, T. P. Dryja, Proc. Natl. Acad. Sci. U.S.A. 92, 3249 (1995); M. Bayes et al., Hum. Mutation 5, 228 (1995); M. Danciger et al., Genomics 3, 1 (1995).
30. M. E. McLaughlin, T. L. Ehrhart, E. L. Berson, T. P. Dryja, Proc. Natl. Acad. Sci. U.S.A. 92, 3249 (1995); M. Bayes et al., Hum. Mutation 5, 228 (1995); M. Danciger et al., Genomics 3, 1 (1995).
31. M. E. McLaughlin, T. L. Ehrhart, E. L. Berson, T. P. Dryja, Proc. Natl. Acad. Sci. U.S.A. 92, 3249 (1995); M. Bayes et al., Hum. Mutation 5, 228 (1995); M. Danciger et al., Genomics 3, 1 (1995).
32. S. H. Huang et al., Invest. Ophthalmol. Vis. Sci. 36, S825 (1995).
33. L. B. Hanh, E. L. Berson, T. P. Dryja, ibid. 35, 1077 (1994).
34. A 0.48-kb Pdeg complementary DNA (cDNA) fragment [N. Tuteja and D. B. Farber, FEBS Lett. 232, 182 (1988)] was used to isolate a 16-kb genomic DNA from a mouse λFixll 129/Sv J library. A targeting vector was constructed by insertion of a 2.0-kb fragment containing exon 2 on the 5′ side, and an 8.5-kb fragment containing exon 4 on the 3′ side, of the neomycin casette of plasmid pPNT (provided by R. Mulligan). DNA was linearized with Sal I before use for electroporation into ES cells. The CCE (provided by E. J. Robertson) and R1 (provided by E. Papaioannou, A, Nagy, R. Nagy, W. Abramow-Newerly, J. Roder, and J. Rossant) [A. Nagy, J. Rossant, R. Nagy, W. Abramow-Newerly, J. C. Roder, Proc. Natl. Acad. Sci. U.S.A. 90, 8424 (1993)] ES cells were cultured, electroporated with the Ω-replacement targeting vector, selected, and screened [P. L. Schwartzberg, S. P. Goff, E. J. Robertson, Science 246, 799 (1989)]. Homologous recombination at the Pdeg locus was further confirmed by digestion of the targeted clones with various enzymes that did not cut the targeting vector.
35. A 0.48-kb Pdeg complementary DNA (cDNA) fragment [N. Tuteja and D. B. Farber, FEBS Lett. 232, 182 (1988)] was used to isolate a 16-kb genomic DNA from a mouse λFixll 129/Sv J library. A targeting vector was constructed by insertion of a 2.0-kb fragment containing exon 2 on the 5′ side, and an 8.5-kb fragment containing exon 4 on the 3′ side, of the neomycin casette of plasmid pPNT (provided by R. Mulligan). DNA was linearized with Sal I before use for electroporation into ES cells. The CCE (provided by E. J. Robertson) and R1 (provided by E. Papaioannou, A, Nagy, R. Nagy, W. Abramow-Newerly, J. Roder, and J. Rossant) [A. Nagy, J. Rossant, R. Nagy, W. Abramow-Newerly, J. C. Roder, Proc. Natl. Acad. Sci. U.S.A. 90, 8424 (1993)] ES cells were cultured, electroporated with the Ω-replacement targeting vector, selected, and screened [P. L. Schwartzberg, S. P. Goff, E. J. Robertson, Science 246, 799 (1989)]. Homologous recombination at the Pdeg locus was further confirmed by digestion of the targeted clones with various enzymes that did not cut the targeting vector.
36. A 0.48-kb Pdeg complementary DNA (cDNA) fragment [N. Tuteja and D. B. Farber, FEBS Lett. 232, 182 (1988)] was used to isolate a 16-kb genomic DNA from a mouse λFixll 129/Sv J library. A targeting vector was constructed by insertion of a 2.0-kb fragment containing exon 2 on the 5′ side, and an 8.5-kb fragment containing exon 4 on the 3′ side, of the neomycin casette of plasmid pPNT (provided by R. Mulligan). DNA was linearized with Sal I before use for electroporation into ES cells. The CCE (provided by E. J. Robertson) and R1 (provided by E. Papaioannou, A, Nagy, R. Nagy, W. Abramow-Newerly, J. Roder, and J. Rossant) [A. Nagy, J. Rossant, R. Nagy, W. Abramow-Newerly, J. C. Roder, Proc. Natl. Acad. Sci. U.S.A. 90, 8424 (1993)] ES cells were cultured, electroporated with the Ω-replacement targeting vector, selected, and screened [P. L. Schwartzberg, S. P. Goff, E. J. Robertson, Science 246, 799 (1989)]. Homologous recombination at the Pdeg locus was further confirmed by digestion of the targeted clones with various enzymes that did not cut the targeting vector.
37. N. P. Skiba, N. O. Artemyev, H. E. Hamm, J. Biol. Chem. 270, 13210 (1995); D. J. Takemoto, D. Hurt, B. Oppert, J. Cunnick, Biochem. J. 281, 637 (1992); V. M. Lipkin, I. L. Dumler, K. G. Muradov, N. O. Artemyev, R. N. Etingof, FEBS. Lett. 234, 287 (1988).
38. N. P. Skiba, N. O. Artemyev, H. E. Hamm, J. Biol. Chem. 270, 13210 (1995); D. J. Takemoto, D. Hurt, B. Oppert, J. Cunnick, Biochem. J. 281, 637 (1992); V. M. Lipkin, I. L. Dumler, K. G. Muradov, N. O. Artemyev, R. N. Etingof, FEBS. Lett. 234, 287 (1988).
39. N. P. Skiba, N. O. Artemyev, H. E. Hamm, J. Biol. Chem. 270, 13210 (1995); D. J. Takemoto, D. Hurt, B. Oppert, J. Cunnick, Biochem. J. 281, 637 (1992); V. M. Lipkin, I. L. Dumler, K. G. Muradov, N. O. Artemyev, R. N. Etingof, FEBS. Lett. 234, 287 (1988).
40. The targeted mutation at the Pdeg locus was introduced into the germ line of chimeric mice by injection of the targeted ES clones into C57BL/6 or MF1 blastocysts that were surgically reimplanted into the uteri of foster mothers [V. E. Papaioannou and R. Johnson, in Gene Targeting, A. L. Joyner, Ed. (Oxford Univ. Press, New York, 1993), pp. 107-146; A. Bradley, in Teratocarcinomas and Embryonic Stem Cells: A Practical Approach, E. J. Robertson, Ed. (IRL, Oxford, 1987), pp. 113-151]. Thirty-six chimeras were bom and mated with C57BL/6 or MF1 mice to test tor germline competency of the targeted clones; 29 of these chimeric mice transmitted the mutant allele. ES cell-derived progeny were identified by coat color and screened for the presence of the targeted allele by Southern blot or polymerase chain reaction (PCR) obtain 0.1 -s pulses that were repeated every 5 to 10 s at high stimulus intensities. The maximal responses at 2 to 3 weeks after birth were 600 to 800 μV from normal mice but only 20 to 30 μV from mutants.
41. The targeted mutation at the Pdeg locus was introduced into the germ line of chimeric mice by injection of the targeted ES clones into C57BL/6 or MF1 blastocysts that were surgically reimplanted into the uteri of foster mothers [V. E. Papaioannou and R. Johnson, in Gene Targeting, A. L. Joyner, Ed. (Oxford Univ. Press, New York, 1993), pp. 107-146; A. Bradley, in Teratocarcinomas and Embryonic Stem Cells: A Practical Approach, E. J. Robertson, Ed. (IRL, Oxford, 1987), pp. 113-151]. Thirty-six chimeras were bom and mated with C57BL/6 or MF1 mice to test tor germline competency of the targeted clones; 29 of these chimeric mice transmitted the mutant allele. ES cell-derived progeny were identified by coat color and screened for the presence of the targeted allele by Southern blot or polymerase chain reaction (PCR) obtain 0.1 -s pulses that were repeated every 5 to 10 s at high stimulus intensities. The maximal responses at 2 to 3 weeks after birth were 600 to 800 μV from normal mice but only 20 to 30 μV from mutants.
42. S. H. Tsang et al., unpublished data.
43. Retinas were fixed by vascular perfusion of the mice with a solution of 3% glutaraldehyde and 1.5% paraformaldehyde in phosphate-buffered saline at pH 7.2. Epon-embedded blocks were prepared as described [P , Gouras, J. Du, H. Kjeldbye, S. Yamamoto, D. Zack, Invest. Ophthalmol. Vis. Sci. 35, 3145 (1994)], Single sections of the retina extending from the ora serrata superiorally to the ora serrata inferiorally, including the optic nerve, were examined by light microscopy; selected areas were also studied by electron microscopy.
44. The assay was done essentially as described [D. B. Farber and R. N. Lolley, Science 186, 449 (1974)], except that the posterior pole of the globe was dissected and homogenized in 0.1N HCl.
45. 2, and 1 mM dithiothreitol. The protein content of each homogenate was determined by standard Lowry assays.
46. J. B. Hurley and L Stryer, J. Boil. Chem. 257, 11094 (1982).
47. Proteins from retinal homogenates were separated by SDS-PAGE with a tris-tricine buffer system and an inverted acrylamide gradient [R. Zardoya et al., Biotechniques 16, 271 (1994)]. Proteins were blotted and probed with MOE, DUEY, or HUEY antiserum and developed with the amplified alkaline phosphatase kit (Bio-Rad).
48. G. Gillespie, R. K. Prusti, E. D. Apel, J. A. Beavo, J. Biol. Chem. 264, 12187 (1989).
49. S. Kroll, W. J. Phillips, R. A. Cerione, ibid., p. 4490.
50. We thank R. Axel, F. Costantini, B. K.-K. Fung, J. L. German III, P. Mombaerts, A. Nagy, V. E, Papaioannou, J. Rossant, A. Tomlinson, D. Warburton, and members of their laboratories for sharing ideas, cell lines, antisera, and equipment, and for critically reading the manuscript; E. Carlson, C.-S. Lin, M. Mendelsohn, and F. Wang for guidance and advice; and members of the Farber, Goff, and Gouras laboratories for support, especially W. Li. S.H.T. is supported by Medical Scientist Training Program fellowship T32 GM 073667-14. Supported by NIH grants EY08285 (D.B.F.) and by grants from the George Gund Foundation and the Foundation Fighting Blindness (D.B.F.). D.B.F. is the recipient of a Senior Scientific Investigator Award from Research to Prevent Blindness. S.P.G. is an Investigator of the Howard Hughes Medical Institute.